Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Paragon Health Neprhology Centre
mi
from
Kalamazoo, MI
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Paragon Health Neprhology Centre
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
St. Clair Nephrology
mi
from
Port Huron, MI
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
St. Clair Nephrology
mi
from
Port Huron, MI
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Southwest Mississippi Nephrology, PLLC
mi
from
Brookhaven, MS
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Southwest Mississippi Nephrology, PLLC
mi
from
Brookhaven, MS
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Southern Clinical Research Group, LLC
mi
from
Gulfport, MS
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Southern Clinical Research Group, LLC
mi
from
Gulfport, MS
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Nephrology and Hypertension Associates, LTD
mi
from
Tupelo, MS
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Nephrology and Hypertension Associates, LTD
mi
from
Tupelo, MS
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Polack Renal, LLC
mi
from
Saint Louis, MO
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Polack Renal, LLC
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Sierra Nevada Nephrology Consultants
mi
from
Reno, NV
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Sierra Nevada Nephrology Consultants
mi
from
Reno, NV
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Renal Medicine Associates
mi
from
Albuquerque, NM
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Renal Medicine Associates
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Advanced Kidney Care of Hudson Valley
mi
from
Poughkeepsie, NY
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Advanced Kidney Care of Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Durham Nephrology Associates
mi
from
Durham, NC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Durham Nephrology Associates
mi
from
Durham, NC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
East Carolina University
mi
from
Greenville, NC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Eastern Nephrology Associates
mi
from
Kinston, NC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Eastern Nephrology Associates
mi
from
Kinston, NC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Eastern Nephrology Associates, PLLC
mi
from
New Bern, NC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Eastern Nephrology Associates, PLLC
mi
from
New Bern, NC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
HNC Dialysis Ltd.
mi
from
Columbus, OH
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
HNC Dialysis Ltd.
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Penn State Health Milton S. Hershey Medical Center
mi
from
Hershey, PA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Penn State Health Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Columbia Nephrology Associates
mi
from
Columbia, SC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Columbia Nephrology Associates
mi
from
Columbia, SC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
South Carolina Nephrology & Hypertension
mi
from
Orangeburg, SC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
South Carolina Nephrology & Hypertension
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Sumter Medical Specialists
mi
from
Sumter, SC
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Sumter Medical Specialists
mi
from
Sumter, SC
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Regional Health Clinical Research
mi
from
Rapid City, SD
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Regional Health Clinical Research
mi
from
Rapid City, SD
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Southwest Houston Research, Ltd
mi
from
Houston, TX
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Southwest Houston Research, Ltd
mi
from
Houston, TX
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Lubbock Vascular Access Center
mi
from
Lubbock, TX
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Lubbock Vascular Access Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Washington Nephrology Associates
mi
from
Alexandria, VA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Washington Nephrology Associates
mi
from
Alexandria, VA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
University Of Virgina Health System
mi
from
Charlottesville, VA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
University Of Virgina Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
TPMG Clinical Research
mi
from
Newport News, VA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
TPMG Clinical Research
mi
from
Newport News, VA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Valley Nephrology Associates
mi
from
Roanoke, VA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Valley Nephrology Associates
mi
from
Roanoke, VA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Nephrology and Hypertension Associates
mi
from
Bluefield, WV
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Nephrology and Hypertension Associates
mi
from
Bluefield, WV
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
West Virginia University
mi
from
Morgantown, WV
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated:  12/31/1969
Aspirius Research Institute
mi
from
Wausau, WI
Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/1969
Aspirius Research Institute
mi
from
Wausau, WI
Click here to add this to my saved trials
Immune Monitoring in Sensitized Patients at Risk of Rejection
Immune Monitoring in Sensitized Patients at Risk of Rejection
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Immune Monitoring in Sensitized Patients at Risk of Rejection
Immune Monitoring in Sensitized Patients at Risk of Rejection
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Shear Wave Elastography in Native Kidney Disease
Shear Wave Elastography in Native Kidney Disease: a Pilot Study
Status: Enrolling
Updated:  12/31/1969
Albert Einstein Healthcare Network
mi
from
Philadelphia, PA
Shear Wave Elastography in Native Kidney Disease
Shear Wave Elastography in Native Kidney Disease: a Pilot Study
Status: Enrolling
Updated: 12/31/1969
Albert Einstein Healthcare Network
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Use of ACE Inhibitors in the Early Renal Post-transplant Period
The Use of ACE Inhibitors in the Early Renal Post-transplant Period
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
The Use of ACE Inhibitors in the Early Renal Post-transplant Period
The Use of ACE Inhibitors in the Early Renal Post-transplant Period
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Alabama
mi
from
Birmingham, AL
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
UCLA
mi
from
Los Angeles, CA
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Children's Healthcare of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Riley Hospital for Children
mi
from
Indianapolis, IN
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Riley Hospital for Children
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Childrens Center
mi
from
Baltimore, MD
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Childrens Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Michigan, Mott Hospital
mi
from
Ann Arbor, MI
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Michigan, Mott Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Levine Children's
mi
from
Charlotte, NC
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Levine Children's
mi
from
Charlotte, NC
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hopsital
mi
from
Columbus, OH
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hopsital
mi
from
Columbus, OH
Click here to add this to my saved trials
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Clinical Evaluation of PROMIS in CKD
Clinical Evaluation of PROMIS Pediatric Person Reported Outcome Measures in Children With Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials